# Hbar Technologies, LLC — Hazardous Materials Safety Interpretation

**Citation:** 04-0085  
**Type / status:** guidance / guidance  
**Agency:** Pipeline and Hazardous Materials Safety Administration  
**Effective:** Not stated  
**Published:** 2004-10-19

04-0085 response to Hbar Technologies, LLC concerning 171.8.

## Document text

<<<PAGE 1>>>

of Transportation
U.S. Department
400 Seventh St., S.W.
Washington, D.C. 20590
Research and
special Programs
OCT 19 2004
Administration
Dr. Gerald P. Jackson
Ref. No. 04-0085
President
Hbar Technologies, LLC
1275 Roosevelt Road, Suite 103
West Chicago, IL 60185
Dear Dr. Jackson:
Thank you for your March 24, 2004 letter regarding the classification of antiprotons under the
Hazardous Material Regulations (HMR; 49 CFR parts 171-180). Specifically, you ask whether
antiprotons, transported in quantities capable of producing a worst case acute exposure to the
public of no more than 2 mrem or 1,000 rem from prompt ionizing radiation, are considered a
hazardous material, and if so, which category (hazard class and division) applies. You state that
the antiprotons are intrinsically stable and would only emit radiation upon contact with residual
gas within the bottle or the walls of the bottle.
Your letter does not provide sufficient information on the hazardous properties of your particular
material, the amount of material to be transported, or the manner in which the material is
packaged to provide you with specific guidance. Nevertheless, based upon the information you
provided, we believe that sufficient quantities of antimatter offered for transportation would meet
the defining criteria of a Class 1 (explosive), a Class 7 (radioactive), and perhaps other Class
material. For example, a dose of 1,000 rem of prompt ionizing radiation to the public is
significantly greater than the defining annual dose criteria for Class 7 (radioactive) material. As
with other hazardous materials, we also believe a graded approach based on the quantities of
antiprotons and their related possible effects would be appropriate.
We recognize that antimatter is not specifically listed in the HMR and the need for possible
future rulemaking on this emerging technology. In order to complete our review of your
proposed single transport of antiprotons later this year from the Fermi National Accelerator
Laboratory in Batavia, IL to the NASA Marshall Space Flight Center in Huntsville, AL, we have
identified the following issues pertaining to your request.
Material
1) Provide information on the material purity as well as the method and accuracy of measuring
the quantities of antiprotons proposed to be transported.
2) Provide the quantities of antiprotons that you may desire to transport, based on your
evaluation of the information requested in this letter.
040085
171.8

<<<PAGE 2>>>

Containment System
3) Describe the antimatter transport bottle, including design features such as materials of
construction, barriers, shielding, vacuum system, cryogenics, superconducting magnets,
detection systems for loss of design feature functions or annihilation of the antiprotons, and
contingency backup systems.
4) Provide information on magnetic fields produced by the bottle system.
5) Describe any other hazardous materials present other than antiprotons, such as helium or
other compressed or liquefied gas, batteries, or fuels.
Failure Modes
6) Detail the processes, such as prolonged or rapid loss of vacuum, cryogenics, or
electromagnetic containment in the transport bottle, that could cause annihilation of the
antiprotons with matter, as well as information on any steady state annihilation.
7) Provide information on any past experience with planned or unplanned stored antiproton
annihilation.
Transport
8) Provide details on the truck and any design features, such as shielding or barriers, to be used
for the transport.
9) Provide details on any operational controls or contingency planning to be used during
transport.
10) Provide details on any personnel or environmental monitoring for hazardous materials to be
instituted during transport, such as dosimetry selection for prompt or delayed radiation
hazards, including radiation type and energy coverage as well as any applicable accreditation.
Consequences
11) Provide the supporting information for the ionizing radiation exposure determination you
and processes, including energies and decay times. Provide information on the total effective
provided from antiproton annihilation with matter, specifying contributions from all products
dose equivalent, deep dose equivalent, committed effective dose equivalent if any, committed
dose equivalent if any, shallow dose equivalent, and lens dose equivalent; and quality factors
used. Include contribution from decay chain daughter products. Provide spatial and time
data.
12) Provide an analysis of the level of safety of the bottle under normal and accident conditions
during transport that could lead to annihilation of the antiprotons with matter.

<<<PAGE 3>>>

13) Provide information on possible fission effects caused by antiproton annihilation with matter,
such as caused by pions or high-energy gamma rays, on any transuranic and fissile material
that may be impacted.
14) Provide information on airborne radioactivity, radioactive material contamination, and
induced activation caused by the antiproton annihilation.
15) Your memo provides data for a single prompt dose to the public. Provide the quantity of
antiprotons that would cause this dose and the assumptions used. Provide the total, and not
just prompt dose, if the total dose is different. Provide estimated total doses to any transport
total doses estimated
workers and the assumptions, such as distance, utilized. Provide a time and spatial plot of
16) Provide data on heat generated and the explosive potential of the antiprotons annihilating
with matter.
17) Explain the correlation of effects based on the quantity of antiprotons, e.g., linearity, or any
phenomena that would cause non-linear or threshold effects based on the quantity of
antiprotons.
General
18) Estimate the margin of error in any calculations or experimental data you provide.
19) Provide references used and details on any computer codes used to provide information
relevant to these issues, and any verification and validation performed.
20) Provide details on the credentials and backgrounds of personnel involved in providing
information relevant to the issues, including peer reviewers.
21) Provide any test data that substantiates calculated data, or of any physical testing that is
planned to be conducted to corroborate any calculated data.
Hazardous Materials Technology, (202) 366-4545.
Should you have further questions on this matter, please contact Mr. Jim Williams, Office of
Sincerely,
Robert A. McGuire
Associate Administrator for
Hazardous Material Safety

<<<PAGE 4>>>

In my opinion, this is a good start at a letter. I have annotated this using the Microsoft Word
indly regard all of my suggestions in the context of USDOT practices and existing Regulation:
rack Changes features for my own convenience. Don Cossairt, October 12, 2004. Pleas
Betts
here at Fermilab who take care of that topic for me!
As I explained over the telephone, 1 am not an expert per se on DOT procedures. We have others
$111.8
Definitions
04-0085
President
Dr. Gerald P. Jackson
Ref. No. 04-0085
1275 Roosevelt Road, Suite 103
Hbar Technologies, LLC
West Chicago, IL 60185
Dear Dr. Jackson:
Hazardous Material Regulations (HMR; 49 CFR parts 171-180). Specifically, you ask whether
Thank you for your March 24, 2004 letter regarding the classification of antiprotons under the
antiprotons, transported in quantities capable of producing a worst case acute exposure to the
hazardous material, and if so, which category (hazard class and division) applies. You state that
public of no more than 2 mrem or 1,000 rem from prompt ionizing radiation, are considered a
gas within the bottle or the walls of the bottle. In my judgment it seems to me Hbar has asked
the antiprotons are intrinsically stable and would only emit radiation upon contact with residual
introduce early in this letter the possibility that several levels of stringency will be required at
for advice over a rather wide range of worst case doses. I suggest that DOT point that out and
different points just like what is done for other ionizing radiation hazards.
material, the amount of material to be transported, or the manner in which the material is
Your letter does not provide sufficient information on the hazardous properties of your particular
provided, we believe that sufficient quantities of antimatter offered for transportation would meet
packaged to provide you with specific guidance. Nevertheless, based upon the information you
the defining criteria of a Class 1 (explosive), a Class 7 (radioactive), and perhaps other Class
you should still list explosive hazard. I believe the latter hazard is more likely to present itself
material. In my view, I would point out Class 7 first, as I think this the "exotic" issue. However
annihilations themselves for the quantities of antiprotons they are talking about transporting. See
due to the nature of the technology used to create the bottle than from the antiproton
omments below concerning other hazards. For example, a dose of 1,000 rem of prompt ionizin
adiation to the public is significantly greater than the defining annual dose criteria for Class
Deleted:
(radioactive) material. Again, the worst case dose is crucial to determining what DOT might
require, I suggest.
We recognize that antimatter is not specifically listed in the HMR and the need for possible
future rulemaking on this emerging technology. In order to complete our review of your
proposed single transport of antiprotons later this year from the Fermi National Accelerator

<<<PAGE 5>>>

identified the following issues pertaining to your request to determine if the proposed quantity
Laboratory in Batavia, IL to the NASA Marshall Space Flight Center in Huntsville, AL, we have
meets the defining criteria for hazard classes and divisions in the HMR.
Material
1)
•Provide information on the material purity as well as the method and accuracy of measuring
the quantities of antiprotons proposed to be transported. This is a good issue. They should be
imagine it will make a difference in what requirements will be prescribed.
able to describe to you how they will know how many antiprotons they have in the bottle as I
2)
Provide the quantities of antiprotons that you may desire to transport, based on your
evaluation of the information requested in this letter. They did. indeed, as for a big range!
Containment System
3) Describe the antimatter transport bottle, including design features such as materials of
construction, barriers, shielding, vacuum system, cryogenics, superconducting magnets, and
detection systems for loss of design feature functions or annihilation of the antiprotons.
4) Provide information on magnetic fields produced by the bottle system. Yes, there will be
stray magnetic fields. In my limited expertise with DOT, I cannot recall any requirements
pertaining to magnetic fields.
5)
Describe any other hazardous materials present, such as helium. Is helium really a hazardous
material per DOT (pardon my ignorance!). Under some situations it can be an asphysixiant.
Failure Modes
6) Detail the processes, such as shock, prolonged or rapid loss of vacuum, cryogenics, or
antiprotons with matter, as well as information on any steady state annihilation. Good issue
electromagnetic containment in the transport bottle that could cause annihilation of the
and loss of electromagnetic containment. You might want to ask about backup systems, if
to raise, you have brought up the 2 key problems that can cause annihilations; loss of vacuum
is a problem but they should address this.
any, that might be present to assure this does not happen. I doubt if steady-state annihilation
7) Provide information on any past experience with planned or unplanned stored antiproton
annihilation.
Transport
8) Provide details on the truck and any design features, such as shielding or barriers, to be used
for the transport. Good.

<<<PAGE 6>>>

9) Provide details on any operational controls or contingency planning to be used during
transport._Good.
10) Provide details on any personnel or environmental monitoring for any hazardous materials
monitoring for possible prompt radiation hazards. I don't believe other hazardous materials
during transport. I suggest restating this point to cover personnel or environmental
choice of dosimetry badge is crucial. Due to the nature of the radiation fields, they would
are a significant issue. However, if it is decided to require personnel monitoring badges, the
have to select dosimeter that is capable of seeing fast neutrons as well as gamma-rays. I
would insist on a NVLAP-accreditated badge inclusive of fast-neutron capability.
Consequences
11) Provide the supporting information for the ionizing radiation exposure determination you
provided from antiproton annihilation with matter, specifying contributions from all products
dose equivalent, deep dose equivalent, committed effective dose equivalent if any, committed
and processes, including energies and decay times. Provide information on the total effective
used. Include contribution from decay chain daughter products. Provide spatial and time
dose equivalent if any, shallow dose equivalent, and lens dose equivalent; and quality factors
them tell you that. From my own work, it will all be deep dose equivalent as all of the major
data. I think this is nearly all a "prompt" situation with insignificant decay products, but let
components of the radiation field have sizeable mean-free paths in tissue. At one point a
effects that my paper didn't and generally underestimated the doses. We'll see what they
crude calculation had been done by one of G. Jackson's partners. However, it left out some
submit here.
12) Provide an analysis of the level of safety of the bottle under normal and accident conditions
comment about failures above.
during transport that could lead to annihilation of the antiprotons with matter. See my
13) Provide information on possible fission caused by antiproton annihilation with matter, such
be impacted. Fission won't be a problem unless they shield the bottle with uranium!
as caused by pions or high-energy gamma rays, on transuranic and fissile material that may
However, should they, for some reason not obvious to me, choose depleted uranium as a
14) Provide information on airborne radioactivity, radioactive material contamination, and
shield to make the thing compact, fission would have to be considered.
induced activation caused by the antiproton annihilation. These should be non-issues for the
guantities envisioned here. However, they should state their conclusions on this.
15) Your memo provides data for a single prompt dose to the public. Provide the quantity of
just prompt dose, if the total dose is different. Provide estimated total doses to any transport
antiprotons that would cause this dose and the assumptions used. Provide the total, and not
total doses estimated._See comment above concerning calculations that might be outdated.
workers and the assumptions, such as distance, utilized. Provide a time and spatial plot of

<<<PAGE 7>>>

16) Provide data on heat generated and the explosive potential of the antiprotons annihilating
with matter.
17) Explain the correlation of effects based on the quantity of antiprotons, e.g., linearity, or any
antiprotons. I don't think there are any such effects but they should be able to demonstrate
phenomena that would cause non-linear or threshold effects based on the quantity of
General
18) Estimate the margin of error in any calculations or experimental data you provide.
19) Provide references used and details on any computer codes used to provide information
relevant to these issues, and any verification and validation performed.
20) Provide details on the credentials and backgrounds of personnel involved in providing
information relevant to the issues, including peer reviewers. I realize that I will have to be
help DOT on this, I will recuse myself from assisting Jackson unless you see this different.
careful here as G. Jackson might come back to me on this! Since I have already agreed to
21) Provide any test data that substantiates calculated data, or of any physical testing that is
planned to be conducted to corroborate any calculated data.
Should you have further questions on this matter, please contact Mr. Jim Williams, Office of
Hazardous Materials Technology, (202) 366-4545.
Sincerely,
Associate Administrator for
Robert A. McGuire
Hazardous Material Safety

## Provenance

- Official: Yes
- Source: <https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040085.pdf>
- Source ID: `phmsa`
- SHA-256: `7e8f6c5b221f294117269529ad0710f5a861eac541ca65e899e3d2e277597b06`
- Retrieved: 2026-08-20T00:59:31.977Z
- Exported: 2026-08-22T19:23:06.591Z
- Document slug: `phmsa-interpretation-04-0085`

### Source metadata

```json
{
  "materialSubtype": "interpretation",
  "interpretationArea": "hazardous_materials",
  "representation": "full_text_from_official_pdf",
  "companies": [
    "Hbar Technologies, LLC"
  ],
  "individuals": [
    "Dr. Gerald P. Jackson"
  ],
  "refIds": [
    "04-0085"
  ],
  "catalogDates": [
    "2004-10-19"
  ],
  "catalogParts": [
    171
  ],
  "catalogRowCount": 1,
  "sourceRecordUrls": [
    "https://www.phmsa.dot.gov/node/49126"
  ],
  "linkedAttachmentUrls": [],
  "unavailableResponseUrls": [],
  "duplicateRepresentationUrls": [],
  "citedSections": [
    "171.8"
  ],
  "catalogPageUrls": [
    "https://www.phmsa.dot.gov/regulations/title49/section/1718"
  ],
  "pdfUrls": [
    "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040085.pdf"
  ],
  "representations": [
    {
      "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040085.pdf",
      "detailUrl": null,
      "detailHtmlPath": null,
      "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040085.pdf",
      "pdfArtifactPath": "data/sources/phmsa-interpretations/04-0085-b69cbbbd1c.pdf",
      "pdfArtifactSha256": "6bdc58245541d9b69b3eb9ac1f8576e63d40d68f77efdcda4adcf408dbd7992f",
      "extractedTextPath": "data/sources/phmsa-interpretations/04-0085-b69cbbbd1c.v2.txt",
      "extractedTextSha256": "c7f58e463204067c3aae319a91eef843d46ccc9baaef4cfb5a4546a4e7f6a97e",
      "pageCount": 7,
      "extractionVersion": 2
    }
  ],
  "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.",
  "jurisdiction": "US"
}
```
